Welcome to PCORI
Please be seated by 8:50 AM ET. The webinar will start at 9:00 AM ET.
Welcome to PCORI Please be seated by 8:50 AM ET. The webinar will - - PowerPoint PPT Presentation
Welcome to PCORI Please be seated by 8:50 AM ET. The webinar will start at 9:00 AM ET. Information for Workgroup Participants Restrooms are located outside near the elevators. Key fobs are available at our front desk. As webinar participants
Please be seated by 8:50 AM ET. The webinar will start at 9:00 AM ET.
2
3
4
5
David G. Armstrong, DPM, MD, PhD Director, Southern Arizona Limb Salvage Alliance (SALSA) Professor of Surgery, University of Arizona College
6
Harry Glauber, MD Endocrinologist, Kaiser Permanente Northwest America’s Health Insurance Plans (AHIP) Representative
7
Michael Herndon, DO Senior Medical Director, Oklahoma Medicaid Medical Directors Network
8
Carolyn Jenkins, DrPH, APRN, LD, RD, FAAN Ann Darlington Edwards Endowed Chair and Professor, Medical University of South Carolina, College of Nursing
9
Lawrence Lavery, DPM, MPH Professor, UT Southwestern Medical Center Co-Director, Plastic Surgery Research Division
10
Joseph W. LeMaster, MD, MPH Primary Care Physician and Associate Professor, The University of Kansas School of Medicine
11
Gayle E. Reiber, PhD, MPH Senior VA Career Scientist Professor, Department of Health Services and Epidemiology, University of Washington
12
Reva Mariah S. ShieldChief AIS Chair, Pawnee Nation College Patient Representative
13
Charlie Steele Board of Directors, The Amputee Coalition
14
Carl D. Stevens, MD, MPH Health Sciences Clinical Professor, David Geffen School of Medicine at UCLA
15
Time Agenda Item 9:00 AM Welcome and Introductions 9:15 AM Introduction to PCORI and Workgroup 9:30 AM Setting the Stage 9:50 AM Perspectives on Priority Topics: Patients, Stakeholders, and Researchers 10:30 AM Break 10:40 AM Perspectives on Priority Topics: Patients, Stakeholders, and Researchers (Continued) 11:45 AM Lunch 12:30 PM Recap of Priority Topics in Lower-Extremity Amputations 12:45 PM Discussion and Consensus around Key Research Gaps 2:15 PM Break 2:25 PM Identification and Refinement of Comparative Effectiveness Research Questions 3:55 PM Next Steps and Wrap-Up 4:00 PM Adjourn
16
17
18
19
interest to patients, their caregivers, and clinicians?
topic and is there ongoing research? How does this help determine whether further research is valuable?
Would new knowledge generated by research be likely to have an impact in practice?
topic remain current for several years, or would it be rendered
better outcomes for particular groups of patients?
20
Cost-effectiveness: PCORI will not answer questions related to cost- effectiveness, costs of treatments or interventions. However, PCORI will consider the measurement of factors that may differentially affect patients’ adherence to the alternatives, such as out-of-pocket costs. Medical billing: PCORI will not address questions about individual insurance coverage or about coverage decisions from third-party payers. Disease processes and causes: PCORI will not consider questions that pertain to risk factors, origin, and mechanisms of diseases or questions related to bench science. Lacking comparative nature or foundation: PCORI will not consider questions that lack any comparative aspect.
21
22
relevant to reducing and eliminating disparities in healthcare outcomes
with the highest potential to reduce and eliminate healthcare disparities
promising/best practices to reduce and eliminate healthcare disparities
23
Topics/Questions proposed for further consideration
Topics come from multiple sources Gap confirmation Priority topics/ questions (Multi-stakeholder Advisory Panels and Workgroups) (PCORI staff in collaboration with AHRQ and others) 1:1 interactions with stakeholders Guidelines development, evidence syntheses Website, staff, Advisory Panel suggestions Board topics Workgroups, roundtables
non- comparative questions
similar questions
research gaps
briefs
24
25
The researchers, patients, and stakeholders who’ve been invited to this workgroup give input during the workgroup. The broad community of researchers, patients, and other stakeholders can give input via our website. Webinar participants can provide input via the webinar “chat” feature.
26
PCORI seeks input on topics to determine specific research gaps on comparative effectiveness research questions.
Participants in this workgroup will be eligible to apply for funding if PCORI decides to produce a funding announcement. The Chair(s) of the workgroup will be eligible to apply for funding should they not participate in any subsequent discussions with PCORI following the workgroup. Input received during the workgroup deliberations are broadcast via webinar, and the webinar is then archived and available to other researchers, patients, or stakeholders on the website. PCORI does not have subsequent discussions with the participants after this workgroup. Participants have been explicitly instructed and are expected to address a set of questions we’ve asked – not to tell us about their research. There should be no “influence advantage” to being a workgroup member, or any knowledge advantage by participating in the workgroup.
27
28
29
30 Claire M. Buckley, Fauzi Ali, Graham Roberts, Patricia M. Kearney, Ivan J. Perry, and Colin P. Bradley, 'Timing of Access to Secondary Healthcare Services for Diabetes Management and Lower Extremity Amputation in People with Diabetes: A Protocol of a Case-Control Study', BMJ Open, 3 (2013), e003871-e71.
31 Division of Diabetes Translation National Center for Chronic Disease Prevention and Health Promotion, 'National Diabetes Statistics Report, 2014' <http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report- web.pdf>
32
7.60% 9% 12.80% 13.20% 15.90% non-Hispanic Whites Asian Americnas Hispanics non-Hispanic blacks American Indians/Alaska Natives
Diabetes Prevalence
Division of Diabetes Translation National Center for Chronic Disease Prevention and Health Promotion, 'National Diabetes Statistics Report, 2014' <http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report- web.pdf>
33
Bradley, 'Timing of Access to Secondary Healthcare Services for Diabetes Management and Lower Extremity Amputation in People with Diabetes: A Protocol of a Case-Control Study', BMJ Open, 3 (2013), e003871-e71.
Hennessy, and Douglas J. Wiebe, 'Location, Location, Location: Geographic Clustering of Lower- Extremity Amputation among Medicare Beneficiaries with Diabetes', Diabetes Care, 34 (2011), 2363- 67.
Marston, Joseph L. Mills, Sr., and Andrew J. M. Boulton, 'Mind the Gap: Disparity between Research Funding and Costs of Care for Diabetic Foot Ulcers', Diabetes Care, 36 (2013), 1815-17.
34
35 Emily A. Cook, Jeremy J. Cook, Magdala Peixoto Labre, Howard Givens, and James J. Diresta, 'The Amputation Prevention Initiative', Journal Of The American Podiatric Medical Association, 104 (2014), 1-10.
36
Minorities', Clinical Orthopaedics & Related Research, 469 (2011), 1941-50.
Nava, Y. Tan, T. Molina, and K. L. Siegel, 'Incidence of Diabetic Foot Ulcer and Lower Extremity Amputation among Medicare Beneficiaries, 2006 to 2008: Data Points #2', in Data Points Publication Series (Rockville MD: 2011).
37 Carl D. Stevens, David L. Schriger, Brian Raffetto, Anna C. Davis, David Zingmond, and Dylan H. Roby, 'Geographic Clustering of Diabetic Lower- Extremity Amputations in Low-Income Regions of California', Health Affairs, 33 (2014), 1383-90.
38
Amputation Prevention Initiative', Journal Of The American Podiatric Medical Association, 104 (2014), 1- 10.
Roby, 'Geographic Clustering of Diabetic Lower-Extremity Amputations in Low-Income Regions of California', Health Affairs, 33 (2014), 1383-90.
39 Emily A. Cook, Jeremy J. Cook, Magdala Peixoto Labre, Howard Givens, and James J. Diresta, 'The Amputation Prevention Initiative', Journal of The American Podiatric Medical Association, 104 (2014), 1-10.
Increased use of screening examinations by physicians and daily self-examinations by patients Referral of at-risk patients to a specialist Smoking cessation Maintenance of glycemic control Management of hypertension, renal disease, and peripheral arterial disease Clinician and patient education
40
Lepantalo, J. L. Mills, J. Reekers, C. P. Shearman, G. Valk, R. E. Zierler, and N. C. Schaper, 'A Systematic Review of the Effectiveness of Revascularization of the Ulcerated Foot in Patients with Diabetes and Peripheral Arterial Disease', Diabetes/Metabolism Research And Reviews, 28 Suppl 1 (2012), 179-217.
41 Kristin M. Lefebvre, and Lawrence A. Lavery, 'Disparities in Amputations in Minorities', Clinical Orthopaedics & Related Research, 469 (2011), 1941-50.
42
43
44
45
46
47
48
Presenter: Carolyn Jenkins, DrPH, APRN, LD, RD, FAAN Ann Darlington Edwards Endowed Chair and Professor, Medical University of South Carolina, College of Nursing
49
Examples:
Expanded Medicaid
50
Examples:
quality diabetes care and foot care) vs. specialty care management (to be defined).
community care system vs. integrated community and clinical care systems (REACH)
51
Examples:
52
53
Presenter: Charlie Steele Board of Directors, The Amputee Coalition
especially in large urban areas
lack of team approach
(INF) provided better long-term outcomes than in skilled nursing facilities (SNF)
54
55
Presenter: Gayle E. Reiber, PhD, MPH Senior VA Career Scientist Professor, Department of Health Services and Epidemiology, University of Washington
56
57
Presenter: Carl D. Stevens, MD, MPH Health Sciences Clinical Professor, David Geffen School of Medicine at UCLA
58
59
Stevens CD, Schriger DL, Raffetto B, Davis AC, Zingmond D, Roby DH. Geographic clustering of diabetic lower-extremity amputations in low-income regions of California. Health Aff (Millwood). 2014 Aug;33(8):1383-90
Home (PCMH) up and running?
60
61
62
63
Presenter: Joseph W. LeMaster, MD, MPH Primary Care Physician and Associate Professor, The University of Kansas School of Medicine
rates and critical ischemia (Morrissey 2007; Amaranto 2009; Rowe 2010; Hughes 2014)
advanced presentation, older age, less statin use (Durham 2010)
less likely to receive
admissions, revascularization, wound debridement, or toe amputation (Holman 2011)
64
65
66
67
Presenter: Harry Glauber, MD Endocrinologist, Kaiser Permanente Northwest America’s Health Insurance Plans (AHIP) Representative
complications
adherence, clinic visits, foot self-care, footwear quality, etc.)
patients (treatment goals, testing rates, choice of medications, use of referrals, etc.)
insurance coverage, convenient availability of care)
68
69
70
71
Presenter: Reva Mariah S. ShieldChief AIS Chair, Pawnee Nation College Patient Representative
as medical staff, want/expect.
72
73
Michael Herndon, DO Senior Medical Director, Oklahoma Medicaid Medical Directors Network
74
75
76
77
Lawrence Lavery, DPM, MPH Professor, UT Southwestern Medical Center Co-Director, Plastic Surgery Research Division
78
79
80
81
82
interest to patients, their caregivers, and clinicians?
topic and is there ongoing research? How does this help determine whether further research is valuable?
Would new knowledge generated by research be likely to have an impact in practice?
topic remain current for several years, or would it be rendered
leads to better outcomes for particular groups of patients?
83
84
85
interest to patients, their caregivers, and clinicians?
topic and is there ongoing research? How does this help determine whether further research is valuable?
Would new knowledge generated by research be likely to have an impact in practice?
topic remain current for several years, or would it be rendered
leads to better outcomes for particular groups of patients?
86
87
88